[帕金森病患者嗅觉功能的多维评估及其与快速眼动睡眠行为障碍的相关性]
1School of Mental Health and Psychological Science, Anhui Medical University, Hefei, 230032, China Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Zhonghua yi xue za zhi
|March 2, 2025
概括
帕金森病 (PD) 患者表现出嗅觉功能受损,特别是在识别方面,使他们与健康个体区分开来. 那些患有REM睡眠行为障碍 (RBD) 的人表现出较差的嗅觉识别,与症状严重程度相关.
科学领域:
- 神经学 神经学
- 嗅觉神经科学是一种神经科学.
- 睡眠医学 睡眠医学
背景情况:
- 嗅觉功能障碍是帕金森病 (PD) 的一个常见的非运动症状.
- 快速眼动睡眠行为障碍 (RBD) 经常与PD相关,可能表明共享的潜在病理生理学.
- 在PD患者中,特定的嗅觉维度和RBD之间的关系需要进一步阐明.
研究的目的:
- 评估不同嗅觉测试在评估PD患者嗅觉功能的诊断价值.
- 探索RBD和没有RBD的PD患者嗅觉功能的临床特征.
- 在PD患者中调查嗅觉尺寸和RBD之间的相关性.
主要方法:
- 对73名PD患者和39名健康对照者的回顾性分析.
- 使用值,歧视和识别测试评估的嗅觉功能.
- 根据RBDSQ,患者被分为患有RBD的PD (PD-RBD+) 和没有RBD的PD (PD-RBD-) 组.
- 采用了接收器操作特征 (ROC) 曲线分析和斯皮尔曼相关性分析.
主要成果:
- 与对照组相比,PD患者在嗅觉值,歧视和识别方面的得分明显较低.
- 嗅觉识别测试显示,在区分PD患者和对照人群中,诊断准确度最高 (AUC=0.829).
- 与PD-RBD-患者相比,PD-RBD+患者的嗅觉识别明显差.
- 嗅觉识别与RBDSQ和PSQI分数负相关,与MoCA分数正相关.
结论:
- 嗅觉值,歧视和识别在PD患者中受损.
- 嗅觉识别测试是区分PD患者与健康个体的宝贵工具.
- 患有RBD的PD患者在嗅觉识别方面有更明显的缺陷,这与症状严重程度有关.
相关概念视频
01:15REM Sleep Behavior Disorder
127
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
127
01:24Parkinson's Disease: Treatment
182
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
182
01:15Parkinson's Disease: Overview
419
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
419